| Literature DB >> 31931765 |
Shunsuke Edakubo1, Kiyohide Fushimi2.
Abstract
BACKGROUND: Anorexia nervosa (AN) is a common eating disorder with the highest mortality rate of all psychiatric diseases. However, few studies have examined inpatient characteristics and treatment for AN. This study aimed to characterise the association between mortality and risk factors in patients with AN in acute-care hospitals.Entities:
Keywords: Anorexia nervosa; Mortality; Risk factor; Sex difference
Mesh:
Year: 2020 PMID: 31931765 PMCID: PMC6958629 DOI: 10.1186/s12888-020-2433-8
Source DB: PubMed Journal: BMC Psychiatry ISSN: 1471-244X Impact factor: 3.630
Patient characteristics and in-hospital deaths
| Deaths (%) | |||
|---|---|---|---|
| Total | 6937 | 195 (2.8) | |
| Sex | <.001 | ||
| Male | 361 (5.2) | 22 (6.1) | |
| Female | 6576 (94.8) | 173 (2.6) | |
| Age at first hospitalization | 0.009 | ||
| 12–15 | 1373 (19.8) | 2 (0.0) | |
| 16–19 | 942 (13.6) | 7 (0.1) | |
| 20–29 | 1262 (18.2) | 18 (0.3) | |
| 30–39 | 1305 (18.8) | 41 (0.6) | |
| 40–49 | 1060 (15.3) | 41 (0.6) | |
| 50–59 | 485 (7.0) | 27 (0.4) | |
| 60–69 | 196 (2.8) | 17 (0.2) | |
| 70–79 | 148 (2.1) | 15 (0.2) | |
| ≥ 80 | 166 (2.4) | 27 (0.4) | |
| Proportion of actual weight to ideal weight ( | <.001 | ||
| 61.5 (9.1) | 55.0 (9.4) | ||
| Charlson Comorbidity Index | <.001 | ||
| 0 | 5913 (85.2) | 127 (1.8) | |
| 1 | 189 (2.7) | 13 (0.2) | |
| 2 | 724 (10.4) | 38 (0.5) | |
| ≥ 3 | 111 (1.6) | 17 (0.2) | |
| Hospital Type | <.001 | ||
| University | 3047 (43.9) | 163 (2.3) | |
| Non-university | 3890 (56.1) | 32 (0.5) | |
| Frequency of hospitalization | 0.128 | ||
| 1 | 4940 (71.2) | 154 (2.2) | |
| 2 | 1141 (16.4) | 23 (0.3) | |
| 3 | 401 (5.8) | 10 (0.1) | |
| 4 | 210 (3.0) | 2 (0.0) | |
| 5 | 70 (1.0) | 3 (0.0) | |
| ≥ 6 | 166 (2.4) | 3 (0.0) | |
| Maximum | 30 | 8 | |
| Physical status at admission | |||
| Bradycardia | 43 (0.6) | 1 (0.0) | 0.999 |
| Hypotension | 146 (2.1) | 34 (0.5) | <.001 |
| Other psychological disorder | |||
| Anxiety disorder | 678 (9.8) | 7 (0.1) | 0.002 |
| Mood disorder | 898 (12.9) | 20 (0.3) | 0.329 |
| Schizophrenia | 533 (7.7) | 12 (0.2) | 0.496 |
| Binge eating and purging | 745 (10.7) | 10 (0.1) | 0.009 |
Risk factors for in-hospital deaths: multivariate logistic regression
| OR | 95% CI | ||
|---|---|---|---|
| Sex (ref. female) | |||
| Male | 2.19 | 1.29–3.73 | .004 |
| Age at first admission | 1.05 | 1.04–1.06 | <.001 |
| Ratio of actual weight to ideal body weight (thinness index) | 0.92 | 0.90–0.94 | <.001 |
| Charlson Comorbidity Index | 1.27 | 1.14–1.42 | <.001 |
| Hospital type (ref. non-university) | |||
| University | 0.45 | 0.30–0.67 | <.001 |
| Frequency of hospitalization | 0.92 | 0.79–1.08 | .322 |
| Use of catecholamine | 8.65 | 5.45–13.7 | <.001 |
| Use of atropine | 0.27 | 0.03–2.12 | .213 |
| Other psychological disorders | |||
| Anxiety disorder | 0.47 | 0.22–1.04 | .063 |
| Mood disorder | 0.80 | 0.49–1.31 | .376 |
| Schizophrenia | 0.99 | 0.53–1.86 | .976 |
| Binge eating and purging | 1.47 | 0.71–3.02 | .296 |
Risk factors for patients aged under 60 years in 6454 patients: multivariate logistic regression
| OR | 95% CI | ||
|---|---|---|---|
| Sex (ref. female) | |||
| Male | 2.40 | 1.00–5.73 | .049 |
| Age at first admission | 1.04 | 1.03–1.06 | <.001 |
| Ratio of actual weight to ideal body weight (thinness index) | 0.91 | 0.89–0.93 | <.001 |
| Charlson Comorbidity Index | 1.28 | 1.11–1.49 | <.001 |
| Hospital type (ref. non-university) | |||
| University | 0.45 | 0.30–0.69 | <.001 |
| Frequency of hospitalization | 0.93 | 0.79–1.10 | .399 |
| Use of catecholamine | 9.82 | 6.00–16.10 | <.001 |
| Use of atropine | 0.27 | 0.03–2.19 | .221 |
| Other psychological disorders | |||
| Anxiety disorder | 0.54 | 0.23–1.27 | .157 |
| Mood disorder | 0.83 | 0.45–1.52 | .550 |
| Schizophrenia | 0.72 | 0.34–1.54 | .397 |
| Binge eating and purging | 1.69 | 0.78–3.65 | .180 |
Risk factors related to re-admission: multivariate logistic regression
| OR | 95% CI | ||
|---|---|---|---|
| Sex (ref. female) | |||
| Male | 0.60 | 0.43–0.84 | .003 |
| Age at first admission | 0.99 | 0.99–0.99 | .008 |
| Ratio of actual weight to ideal body weight (thinness index) | 0.99 | 0.98–0.99 | <.001 |
| Charlson Comorbidity Index | 1.28 | 1.12–1.38 | <.001 |
| Hospital type (ref. non-university) | |||
| University | 1.47 | 1.30–1.67 | <.001 |
| Use of catecholamine | 1.90 | 1.19–3.03 | .007 |
| Use of atropine | 0.67 | 0.29–1.54 | .341 |
| Other psychological disorders | |||
| Anxiety disorder | 1.94 | 1.60–2.36 | <.001 |
| Mood disorder | 1.76 | 1.47–2.09 | <.001 |
| Schizophrenia | 2.58 | 2.09–3.19 | <.001 |
| Binge eating and purging | 32.60 | 19.7–54.10 | <.001 |
| Psychotherapy | 2.56 | 2.01–3.26 | <.001 |
| Intravenous hyperalimentation | 1.99 | 1.75–2.26 | <.001 |
| Major surgery | 1.87 | 0.85–4.15 | .123 |
| General anaesthesia | 2.12 | 1.28–3.52 | .004 |
| Blood transfusion | 0.70 | 0.45–1.10 | .122 |
| Use of anti-arrhythmia agents | 1.98 | 0.94–4.17 | .072 |
Risk factors for in-hospital deaths: multivariate logistic regression
| OR | 95% CI | ||
|---|---|---|---|
| Sex (ref. female) | |||
| Male | 1.94 | 1.12–3.38 | .019 |
| Age at first admission | 1.04 | 1.03–1.05 | <.001 |
| Proportion of actual weight to ideal body weight (thinness index) | 0.93 | 0.91–0.95 | <.001 |
| Charlson Comorbidity Index | 1.22 | 1.09–1.37 | <.001 |
| Hospital type (ref. non-university) | |||
| Academic | 0.48 | 0.31–0.75 | .001 |
| Frequency of hospitalization | 0.93 | 0.79–1.09 | .373 |
| Use of catecholamine | 3.76 | 2.21–6.39 | <.001 |
| Use of atropine | 0.07 | 0.06–0.91 | .042 |
| Other psychological disorders | |||
| Anxiety disorder | 0.59 | 0.26–1.33 | .203 |
| Mood disorder | 0.80 | 0.48–1.35 | .406 |
| Schizophrenia | 1.03 | 0.52–2.03 | .938 |
| Binge eating and purging | 0.20 | 0.09–0.45 | <.001 |
| Psychotherapy | 0.38 | 0.27–0.53 | <.001 |
| Intravenous hyperalimentation | 2.25 | 1.54–3.28 | <.001 |
| Major surgery | 0.98 | 0.13–7.52 | .985 |
| General anaesthesia | 0.11 | 0.002–0.46 | .003 |
| Blood transfusion | 9.81 | 6.13–15.7 | <.001 |
| Use of anti-arrhythmia agents | 5.23 | 2.25–12.2 | <.001 |